Teleflex, whose shares sank nearly 20% Thursday, will acquire most of Biotronik’s vascular intervention assets. Teleflex also ...

Teleflex's (NYSE: TFX) fourth-quarter 2024 earnings conference call, held on February 27, 2025, revealed significant ...

Medical devices provider, Teleflex (NYSE:TFX) said on Thursday that it will acquire all of the vascular intervention business ...

Biotronik today announced a strategic shift that includes the divestiture of its Vascular Intervention (VI) business to ...

Teleflex management announced a significant acquisition and business split, but the market reacted negatively. Read why I ...

Teleflex has announced a plan to split its business into two separate independent companies—and it’s setting up one of its ...

In a flurry of news releases on Feb. 27, Teleflex Inc. reported plans to buy the vascular intervention business of Biotronik ...

Teleflex will acquire Biotronik's Vascular Intervention business for €760 million. Every week, our Whisper Index uncovers ...

After the split, Teleflex would focus on devices for bloodstream and heart procedures, along with medical imaging, while ...

The "Europe Implantable Loop Recorders Market: Analysis and Forecast, 2025-2035" report has been added to ResearchAndMarkets.com's offering. Key players in the market are Medtronic PLC., Abbott ...

Acquisition will further advance Teleflex’s Interventional portfolio with a differentiated global suite of coronary vascular ...

Teleflex (TFX) announced it has entered into a definitive agreement to acquire substantially all of the Vascular Intervention business of ...